BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18508994)

  • 21. Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.
    Wagner KU; Rui H
    J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):93-103. PubMed ID: 18228120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
    Peck AR; Witkiewicz AK; Liu C; Klimowicz AC; Stringer GA; Pequignot E; Freydin B; Yang N; Ertel A; Tran TH; Girondo MA; Rosenberg AL; Hooke JA; Kovatich AJ; Shriver CD; Rimm DL; Magliocco AM; Hyslop T; Rui H
    Breast Cancer Res; 2012 Oct; 14(5):R130. PubMed ID: 23036105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
    Dentelli P; Traversa M; Rosso A; Togliatto G; Olgasi C; Marchiò C; Provero P; Lembo A; Bon G; Annaratone L; Sapino A; Falcioni R; Brizzi MF
    Cell Cycle; 2014; 13(11):1811-26. PubMed ID: 24736554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
    Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
    Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Notch3 restricts metastasis of breast cancers through regulation of the JAK/STAT5A signaling pathway.
    Chen MN; Fang ZX; Wu Z; Bai JW; Li RH; Wen XF; Zhang GJ; Liu J
    BMC Cancer; 2023 Dec; 23(1):1257. PubMed ID: 38124049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.
    Gu L; Dagvadorj A; Lutz J; Leiby B; Bonuccelli G; Lisanti MP; Addya S; Fortina P; Dasgupta A; Hyslop T; Bubendorf L; Nevalainen MT
    Am J Pathol; 2010 Apr; 176(4):1959-72. PubMed ID: 20167868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic role of STAT5a across cancer types.
    Maninang C; Li J; Li WX
    Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible role of Stat5a in rat mammary gland carcinogenesis.
    Shan L; Yu M; Clark BD; Snyderwine EG
    Breast Cancer Res Treat; 2004 Dec; 88(3):263-72. PubMed ID: 15609129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.
    Hoang DT; Gu L; Liao Z; Shen F; Talati PG; Koptyra M; Tan SH; Ellsworth E; Gupta S; Montie H; Dagvadorj A; Savolainen S; Leiby B; Mirtti T; Merry DE; Nevalainen MT
    Mol Cancer Ther; 2015 Mar; 14(3):713-26. PubMed ID: 25552366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.
    Furth PA; Nakles RE; Millman S; Diaz-Cruz ES; Cabrera MC
    Breast Cancer Res; 2011 Oct; 13(5):220. PubMed ID: 22018398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
    Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
    Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.
    Subtil-Rodríguez A; Millán-Ariño L; Quiles I; Ballaré C; Beato M; Jordan A
    Mol Cell Biol; 2008 Jun; 28(11):3830-49. PubMed ID: 18378698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
    Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
    Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K; Haftchenary S; Gunning P; Singh G
    Mol Cell Biochem; 2015 Jul; 405(1-2):205-21. PubMed ID: 25896132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cells with minimal expression of the JAK/STAT pathway related proteins STAT5a and the prolactin receptor: evidence of an alternate prolactin receptor isoform in breast disease.
    Bratthauer GL; Stamatakos MD; Vinh TN
    Protein Pept Lett; 2010 Jan; 17(1):104-8. PubMed ID: 20214633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT5A/B gene locus undergoes amplification during human prostate cancer progression.
    Haddad BR; Gu L; Mirtti T; Dagvadorj A; Vogiatzi P; Hoang DT; Bajaj R; Leiby B; Ellsworth E; Blackmon S; Ruiz C; Curtis M; Fortina P; Ertel A; Liu C; Rui H; Visakorpi T; Bubendorf L; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Nevalainen MT
    Am J Pathol; 2013 Jun; 182(6):2264-75. PubMed ID: 23660011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
    Yip SH; Eguchi R; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.